Introduction: Systemic lupus erythematosus (SLE) belongs to a family of related autoimmune rheumatic disorders that are capable of affecting multiple organs, and they are all associated with a variety of autoantibodies. Henoch Schoenlein purpura (HSP) is a sort of systemic vasculitis that is not associated with auto-antibodies and can affect different organs including the kidneys.
Introduction
Systemic lupus erythematosus (SLE) belongs to a family of related autoimmune rheumatic disorders, including dermatomyositis, scleroderma, polymyositis, mixed connective tissue disease, and rheumatoid arthritis. All of these disorders are capable of affecting multiple organs, and they are all associated with a variety of autoantibodies that rise and fall depending on the clinical disease pattern and/or the treatment given. Because symptoms in systemic rheumatic diseases often overlap, the diagnosis of SLE is not always clear-cut and true overlapping has been frequently reported in the literature. Henoch Schoenlein purpura (HSP) is a sort of systemic vasculitis that is not associated with auto-antibodies and can affect different organs including the kidneys. Its diagnosis is mainly clinical. We report on a case that presented with "typical" clinical features of Henoch-Schoenlein purpura with renal biopsy features of IgA nephropathy. At a later stage the full blown features of systemic lupus erythematosus became apparent.
Case report
A 12 year-old previously healthy girl, was referred to our hospital with a history of recent symptoms including abdominal pain, low grade fever, swollen and tender feet and left hand, skin rash on the lower extremities, left-sided neck pain and vomiting. On presentation her general condition was stable but her blood pressure was 138/100 mmHg and her temperature 37. 8 Clinically the purpuric rash lasted two days then started to fade out, even before steroids were started. Four weeks after starting treatment all clinical complaints resolved and C3 and ESR normalized. The proteinuria started to decrease slowly but significantly after three months of treatment. Four months later the proteinuria dropped to 0.6 g/day, the RBCs in urine to 20/µl and serum albumin increased to 30 g/l. MMF and Prednisolone were given for a total treatment time of 5.5 months, and then they were tapered-off and discontinued.
One month after withdrawal of her medications, the patient came with chest pain, abdominal pain and mild guarding. Echocardiography revealed minimal pericardial effusion while abdominal and chest ultrasound showed moderate left sided pleural effusion. This was diagnosed as serositis. The lab tests revealed a rise in the proteinuria to 8 g/day. The other tests were as follows: RBCs in urine >100/µl, ESR 36 mm/hour, Albumin 23 g/l, antinuclear antibodies (ANA) 3+ positive, anti dsDNA 225 (cut off 30), and hemoglobin 10.5 g/dl. Serum albumin then dropped to 19 g/l.
It was clinically and serologically evident at this point that the patient had SLE disease, with 5 out of 11 criteria of the American Rheumatism Association (ARA).
Immunosuppressive treatment was restarted using pulse methylprednisolone followed by oral prednisolone at a dose of 80 mg daily and MMF 750 mg twice daily. Hydroxychloroquine was also added. After starting this treatment the clinical and biochemical status improved, reflected by the disappearance of symptoms and the regression of proteinuria as well as normalization of C3, C4 and decrease of anti-dsDNA titer. Ten months later the laboratory tests showed fairly well controlled SLE including 24 hour urine protein of 0.2 g/day, normal C3 and C4 complement, anti dsDNA 42 IU/ml and ESR 18 mm/hr. The urine sediment was almost normal.
Discussion
To the best of our knowledge this is the first reported case of SLE that clinically presented as HSP with severe renal involvement as nephrotic-nephritic syndrome and later-on developed clinical and laboratory manifestations of SLE with markedly positive serology. Systemic lupus erythematosus (SLE) belongs to a family of related autoimmune rheumatic disorders, including dermatomyositis, scleroderma, polymyositis, mixed connective tissue disease, and rheumatoid arthritis. All of these disorders are capable of affecting multiple organs, and the symptoms in systemic rheumatic diseases often overlap as has been repeatedly reported in the literature [1] [2] [3] [4] [5] [6] [7] [8] [9] .
In our case, the initial clinical diagnosis of HenochSchoenlein Purpura was clinically confirmed by three different skilled pediatricians. The renal histology was a diffuse proliferative glomerulonephritis with fibrinogen and C3 deposits which can be a feature of either HSP or SLE nephritis. However, the positive immunostaining for IgA in renal biopsy gave more support to the clinical diagnosis of HSP. The low level of complement C3 has been described occasionally in HSP cases in the literature [10] and deposition of IgA in the kidney are typical finding in HSP nephritis [11] .
The initial clinical and laboratory response after starting the intensified immunosuppressive treatment with steroids and MMF was first regarded as one of two SLE that mimicked Henoch-Schoenlein Purpura possibilities: first, the glomerulonephritis responded well to this treatment; second, this could have been a spontaneous improvement of HSP nephritis. Because data from randomized clinical trials are sparse, there is no clear path for treatment recommended for the established renal disease in HSP [12, 13] .
However, as the patient developed frank clinical and laboratory manifestation of SLE after discontinuation of this treatment, we retrospectively proposed that this could have been a good response of SLE nephritis to immunosuppressive therapy [14, 15] .
Conclusion
In conclusion, this case presented with clinical features of Henoch-Schoenlein purpura and later-on presented with findings supporting the diagnosis of systemic lupus erythematosus. To the best of our knowledge, this kind of clinical overlapping has not been reported in the literature so far.
